Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$1.84.

  • Precision Biosciences' EPS (Basic) rose 1822.22% to -$1.84 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0, marking a year-over-year decrease of 1010000.0%. This contributed to the annual value of $1.05 for FY2024, which is 10657.89% up from last year.
  • Per Precision Biosciences' latest filing, its EPS (Basic) stood at -$1.84 for Q3 2025, which was up 1822.22% from -$2.13 recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' EPS (Basic) peaked at $4.7 during Q2 2024, and registered a low of -$37.06 during Q4 2022.
  • Over the past 5 years, Precision Biosciences' median EPS (Basic) value was -$1.84 (recorded in 2025), while the average stood at -$3.23.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 965263.16% in 2022, then soared by 25015.97% in 2024.
  • Precision Biosciences' EPS (Basic) (Quarter) stood at -$0.38 in 2021, then crashed by 9652.63% to -$37.06 in 2022, then surged by 89.04% to -$4.06 in 2023, then rose by 14.41% to -$3.47 in 2024, then skyrocketed by 47.05% to -$1.84 in 2025.
  • Its EPS (Basic) stands at -$1.84 for Q3 2025, versus -$2.13 for Q2 2025 and -$2.21 for Q1 2025.